New eczema drug SYX-5219 enters first human safety trials
NCT ID NCT07558668
First seen May 01, 2026 · Last updated May 16, 2026 · Updated 4 times
Summary
This early-stage study tests a new drug called SYX-5219 in healthy people and those with moderate to severe atopic dermatitis (eczema). The main goal is to check safety and how the body processes the drug. Up to 149 participants will receive either the drug or a placebo over several weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE-TO-SEVERE ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sitryx Clinical Site
RECRUITINGArkansas City, Arkansas, 72117, United States
-
Sitryx Clinical Site
RECRUITINGFremont, California, 94538, United States
-
Sitryx Clinical Site
RECRUITINGPlainfield, Indiana, 46168, United States
-
Sitryx Clinical Site
RECRUITINGBoardman, Ohio, 44512, United States
-
Sitryx Clinical Site
RECRUITINGPhiladelphia, Pennsylvania, 19103, United States
-
Sitryx Clinical Site
RECRUITINGBountiful, Utah, 84010, United States
-
Sitryx Clinical Site
RECRUITINGSofia, 1404, Bulgaria
-
Sitryx Clinical Site
NOT_YET_RECRUITINGHerlev, Herlev, 2730, Denmark
-
Sitryx Clinical Site
RECRUITINGBerlin, 10117, Germany
-
Sitryx Clinical Site
RECRUITINGFrankfurt, 60596, Germany
-
Sitryx Clinical Site
ACTIVE_NOT_RECRUITINGFreiburg im Breisgau, 79106, Germany
-
Sitryx Clinical Site
RECRUITINGDublin, D08 NHY1, Ireland
-
Sitryx Clinical Site
RECRUITINGManchester, M23 9QZ, United Kingdom
-
Sitryx Clinical Site
RECRUITINGMerthyr Tydfil, CF48 4DR, United Kingdom
Conditions
Explore the condition pages connected to this study.